These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18647321)

  • 1. Allergenicity, immunogenicity and dose-relationship of three intact allergen vaccines and four allergoid vaccines for subcutaneous grass pollen immunotherapy.
    Henmar H; Lund G; Lund L; Petersen A; Würtzen PA
    Clin Exp Immunol; 2008 Sep; 153(3):316-23. PubMed ID: 18647321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of allergenicity and immunogenicity of an intact allergen vaccine and commercially available allergoid products for birch pollen immunotherapy.
    Lund L; Henmar H; Würtzen PA; Lund G; Hjortskov N; Larsen JN
    Clin Exp Allergy; 2007 Apr; 37(4):564-71. PubMed ID: 17430354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical modification of birch allergen extract leads to a reduction in allergenicity as well as immunogenicity.
    Würtzen PA; Lund L; Lund G; Holm J; Millner A; Henmar H
    Int Arch Allergy Immunol; 2007; 144(4):287-95. PubMed ID: 17641548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Intact Allergen Extracts and Allergoids For Subcutaneous Immunotherapy: The Effect of Chemical Modification Differs Both Between Species and Between Individual Allergen Molecules.
    Henmar H; Nedergaard Larsen J; Lund L; Hvalsøe Meno K; Ferreras M
    J Investig Allergol Clin Immunol; 2023 Jun; 33(3):190-199. PubMed ID: 35088765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An alternative allergen:adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment of grass-pollen allergy.
    Rask C; Lund L; Lund G; Heydenreich B; Wurtzen P; Bellinghausen I; Saloga J; Lund K
    Clin Exp Allergy; 2012 Sep; 42(9):1356-68. PubMed ID: 22925322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response relationship of a new Timothy grass pollen allergoid in comparison with a 6-grass pollen allergoid.
    Pfaar O; Hohlfeld JM; Al-Kadah B; Hauswald B; Homey B; Hunzelmann N; Schliemann S; Velling P; Worm M; Klimek L
    Clin Exp Allergy; 2017 Nov; 47(11):1445-1455. PubMed ID: 28696503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant effects of aluminium hydroxide-adsorbed allergens and allergoids - differences in vivo and in vitro.
    Heydenreich B; Bellinghausen I; Lund L; Henmar H; Lund G; Adler Würtzen P; Saloga J
    Clin Exp Immunol; 2014 Jun; 176(3):310-9. PubMed ID: 24528247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of basophil-activating capacity of grass pollen allergens, allergoids and hypoallergenic recombinant derivatives by flow cytometry using anti-CD203c.
    Kahlert H; Cromwell O; Fiebig H
    Clin Exp Allergy; 2003 Sep; 33(9):1266-72. PubMed ID: 12956749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy.
    Zieglmayer P; Focke-Tejkl M; Schmutz R; Lemell P; Zieglmayer R; Weber M; Kiss R; Blatt K; Valent P; Stolz F; Huber H; Neubauer A; Knoll A; Horak F; Henning R; Valenta R
    EBioMedicine; 2016 Sep; 11():43-57. PubMed ID: 27650868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced in vitro T-cell responses induced by glutaraldehyde-modified allergen extracts are caused mainly by retarded internalization of dendritic cells.
    Heydenreich B; Bellinghausen I; Lorenz S; Henmar H; Strand D; Würtzen PA; Saloga J
    Immunology; 2012 Jun; 136(2):208-17. PubMed ID: 22348538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1.
    Sirvent S; Soria I; Cirauqui C; Cases B; Manzano AI; Diez-Rivero CM; Reche PA; López-Relaño J; Martínez-Naves E; Cañada FJ; Jiménez-Barbero J; Subiza J; Casanovas M; Fernández-Caldas E; Subiza JL; Palomares O
    J Allergy Clin Immunol; 2016 Aug; 138(2):558-567.e11. PubMed ID: 27177779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grass pollen allergoids conjugated with mannan for subcutaneous and sublingual immunotherapy: a dose-finding study.
    Ojeda P; Barjau MC; Subiza J; Moreno A; Ojeda I; Solano E; Alonso A; Caballero R; Del Pozo S; Gómez-Perosanz M; Sánchez-Trincado JL; Benito-Villalvilla C; Angelina A; Soria I; Reche PA; Palomares O; Subiza JL; Casanovas M
    Front Immunol; 2024; 15():1431351. PubMed ID: 38989287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of T cells with grass pollen allergen extract and allergoid.
    Kahler H; Stüwe H; Cromwell O; Fiebig H
    Int Arch Allergy Immunol; 1999 Oct; 120(2):146-57. PubMed ID: 10545769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of a residual group in low-molecular-weight allergoids of Artemisia vulgaris pollen on their allergenicity, IgE- and IgG-binding properties.
    Cirković T; Gavrović-Jankulović M; Prisić S; Jankov RM; Burazer L; Vucković O; Sporcić Z; Paranos S
    Allergy; 2002 Nov; 57(11):1013-20. PubMed ID: 12358997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell RNA sequencing identifies precise tolerogenic cellular and molecular pathways induced by depigmented-polymerized grass pollen allergen extract.
    Layhadi JA; Moya R; Tan TJ; Lenormand MM; Sharif H; Parkin RV; Vila-Nadal G; Fedina O; Zhu R; Laisuan W; Durham SR; Carnés J; Shamji MH
    J Allergy Clin Immunol; 2023 May; 151(5):1357-1370.e9. PubMed ID: 36649758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.
    Focke-Tejkl M; Weber M; Niespodziana K; Neubauer A; Huber H; Henning R; Stegfellner G; Maderegger B; Hauer M; Stolz F; Niederberger V; Marth K; Eckl-Dorna J; Weiss R; Thalhamer J; Blatt K; Valent P; Valenta R
    J Allergy Clin Immunol; 2015 May; 135(5):1207-7.e1-11. PubMed ID: 25441634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell reactivity with allergoids: influence of the type of APC.
    Kahlert H; Grage-Griebenow E; Stüwe HT; Cromwell O; Fiebig H
    J Immunol; 2000 Aug; 165(4):1807-15. PubMed ID: 10925258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines.
    Manzano AI; Javier Cañada F; Cases B; Sirvent S; Soria I; Palomares O; Fernández-Caldas E; Casanovas M; Jiménez-Barbero J; Subiza JL
    Glycoconj J; 2016 Feb; 33(1):93-101. PubMed ID: 26603537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact on Allergy-Related Cells of a Birch Pollen Allergoid, with and without Monophosphoryl Lipid A, in Comparison with the Native Equivalent.
    Worm M; Ernst D; Kraller M; Babina M
    Int Arch Allergy Immunol; 2017; 172(1):20-26. PubMed ID: 28219062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergoid-specific T-cell reaction as a measure of the immunological response to specific immunotherapy (SIT) with a Th1-adjuvanted allergy vaccine.
    von Baehr V; Hermes A; von Baehr R; Scherf HP; Volk HD; Fischer von Weikersthal-Drachenberg KJ; Woroniecki S
    J Investig Allergol Clin Immunol; 2005; 15(4):234-41. PubMed ID: 16433203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.